Cargando…
Mechanism of Antibacterial Activity of Bacillus amyloliquefaciens C-1 Lipopeptide toward Anaerobic Clostridium difficile
Probiotics may offer an attractive alternative for standard antibiotic therapy to treat Clostridium difficile infections (CDI). In this study, the antibacterial mechanism in vitro of newly isolated B. amyloliquefaciens C-1 against C. difficile was investigated. The lipopeptides surfactin, iturin, an...
Autores principales: | Lv, Jia, Da, Rong, Cheng, Yue, Tuo, Xiaohong, Wei, Jie, Jiang, Kaichong, Monisayo, Adediji Omolade, Han, Bei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073505/ https://www.ncbi.nlm.nih.gov/pubmed/32190658 http://dx.doi.org/10.1155/2020/3104613 |
Ejemplares similares
-
Lipopeptides as main ingredients for inhibition of fungal phytopathogens by Bacillus subtilis/amyloliquefaciens
por: Cawoy, Hélène, et al.
Publicado: (2015) -
Characterization of lpaH2 gene corresponding to lipopeptide synthesis in Bacillus amyloliquefaciens HAB-2
por: Jin, Pengfei, et al.
Publicado: (2017) -
Variants of lipopeptides and glycolipids produced by Bacillus amyloliquefaciens and Pseudomonas aeruginosa cultured in different carbon substrates
por: Ndlovu, Thando, et al.
Publicado: (2017) -
Systemically engineering Bacillus amyloliquefaciens for increasing its antifungal activity and green antifungal lipopeptides production
por: Wang, Susheng, et al.
Publicado: (2022) -
Bacillus amyloliquefaciens YN201732 Produces Lipopeptides With Promising Biocontrol Activity Against Fungal Pathogen Erysiphe cichoracearum
por: Jiao, Rong, et al.
Publicado: (2021)